These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model. Shreewastav RK; Ali R; Uppada JB; Rao DN Cell Immunol; 2012; 278(1-2):55-62. PubMed ID: 23121976 [TBL] [Abstract][Full Text] [Related]
9. Platycodin d improves the immunogenicity of newcastle disease virus-based recombinant avian influenza vaccine in mice. Xie Y; Sun HX; Li D Chem Biodivers; 2010 Mar; 7(3):677-89. PubMed ID: 20232336 [TBL] [Abstract][Full Text] [Related]
10. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague. Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836 [TBL] [Abstract][Full Text] [Related]
11. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague. Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform. Fischer NO; Weilhammer DR; Dunkle A; Thomas C; Hwang M; Corzett M; Lychak C; Mayer W; Urbin S; Collette N; Chiun Chang J; Loots GG; Rasley A; Blanchette CD PLoS One; 2014; 9(3):e93342. PubMed ID: 24675794 [TBL] [Abstract][Full Text] [Related]
13. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor. Abramov VM; Khlebnikov VS; Vasiliev AM; Kosarev IV; Vasilenko RN; Kulikova NL; Khodyakova AV; Evstigneev VI; Uversky VN; Motin VL; Smirnov GB; Brubaker RR J Proteome Res; 2007 Jun; 6(6):2222-31. PubMed ID: 17441749 [TBL] [Abstract][Full Text] [Related]
14. The impact of size on particulate vaccine adjuvants. Shah RR; O'Hagan DT; Amiji MM; Brito LA Nanomedicine (Lond); 2014 Dec; 9(17):2671-81. PubMed ID: 25529570 [TBL] [Abstract][Full Text] [Related]
15. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model. Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248 [TBL] [Abstract][Full Text] [Related]
16. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice]. Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095 [TBL] [Abstract][Full Text] [Related]
17. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections. Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs. Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883 [TBL] [Abstract][Full Text] [Related]
19. An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system. Moyle PM; Hartas J; Henningham A; Batzloff MR; Good MF; Toth I Nanomedicine; 2013 Oct; 9(7):935-44. PubMed ID: 23428988 [TBL] [Abstract][Full Text] [Related]
20. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant. Chaitra MG; Nayak R; Shaila MS Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]